Mayer Brown announced that the firm has filed a lawsuit on behalf of 3M Company in federal court in California against Utah-based Rx2Live, LLC for an alleged deceptive price-gouging scheme directed at Fresno, California-based healthcare provider Community Medical Centers, Inc. (CMC).
The lawsuit asserts that Rx2Live falsely claimed that it could source millions of 3M
As the Covid-19 virus continues to wreak havoc, governments around the world are urging companies to organise remote working for their staff – wherever possible.
While this is a positive development for public health and economic considerations, companies should be aware that migrating all employees to home working could create additional challenges in software license compliance. As it turns out, remote access is the easiest way to quickly become non-compliant with many software vendors.
Continue Reading New Focus on Software Audits as a Result of Covid-19
Current as of April 6, 2020
In response to the COVID-19 crisis, intellectual property (IP) offices around the world are taking steps to address the impact that stay-at-home orders may have on IP practitioners and their own operations. Such measures include extensions to deadlines related to the prosecution of patents, trademarks, and copyrights. In the United States, however, these extensions apply only to certain deadlines, and only to those persons materially affected by the COVID-19 outbreak.
This legal update describes temporary relief at the United States Patent and Trademark Office (USPTO) and the IP offices of several foreign jurisdictions, highlighting notable extensions—and the lack thereof—that could potentially affect the registration of patents, trademarks, and copyrights. This update also presents best practices for protecting and maintaining one’s registered IP rights during the outbreak.
Continue Reading Impact of COVID-19 in Intellectual Property
There is a lot of uncertainty as to when the Brazilian Data Protection Law (No. 13,709 – “LGPD”) will come into force. Such uncertainly has been significantly increased due to the current scenario of Covid-19. However, data protection compliance projects should not be postponed or implemented superficially, especially considering (i) their direct impact in a
On March 31, 2020, the United States Patent Office (USPTO) announced extensions for certain fees and deadlines during the coronavirus (COVID-19) pandemic. Citing the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), the $2 trillion relief bill signed by President Trump on March 27, the USPTO extended most deadlines for patent and trademark filings and fees that would have otherwise been due between March 27, 2020 and April 30, 2020.
Continue Reading USPTO Extends Deadlines under the Coronavirus Aid, Relief, and Economic Security Act